Recent Advances and Clinical Outcomes of Kidney Transplantation
Open Access
- 21 April 2020
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4), 1193
- https://doi.org/10.3390/jcm9041193
Abstract
Recent advances in surgical, immunosuppressive and monitoring protocols have led to the significant improvement of overall one-year kidney allograft outcomes. Nonetheless, there has not been a significant change in long-term kidney allograft outcomes. In fact, chronic and acute antibody-mediated rejection (ABMR) and non-immunological complications following kidney transplantation, including multiple incidences of primary kidney disease, as well as complications such as cardiovascular diseases, infections, and malignancy are the major factors that have contributed to the failure of kidney allografts. The use of molecular techniques to enhance histological diagnostics and noninvasive surveillance are what the latest studies in the field of clinical kidney transplant seem to mainly focus upon. Increasingly innovative approaches are being used to discover immunosuppressive methods to overcome critical sensitization, prevent the development of anti-human leukocyte antigen (HLA) antibodies, treat chronic active ABMR, and reduce non-immunological complications following kidney transplantation, such as the recurrence of primary kidney disease and other complications, such as cardiovascular diseases, infections, and malignancy. In the present era of utilizing electronic health records (EHRs), it is strongly believed that big data and artificial intelligence will reshape the research done on kidney transplantation in the near future. In addition, the utilization of telemedicine is increasing, providing benefits such as reaching out to kidney transplant patients in remote areas and helping to make scarce healthcare resources more accessible for kidney transplantation. In this article, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored.This publication has 161 references indexed in Scilit:
- Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT TrialAmerican Journal of Transplantation, 2012
- Hypertension in kidney transplant recipientsTransplant International, 2011
- Malignancy after renal transplantation: the role of immunosuppressionNature Reviews Nephrology, 2010
- New-onset diabetes after transplantation: a review of recent literatureCurrent Opinion in Organ Transplantation, 2009
- Kidney Transplantation as Primary Therapy for End-Stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2008
- Clinical Practice Guidelines for Managing Dyslipidemias in Kidney Transplant Patients: Lessons to be Learnt From the Assessment of Lescol® in Renal Transplantation (ALERT) TrialAmerican Journal of Transplantation, 2005
- Clinical Practice Guidelines for Managing Dyslipidemias in Kidney Transplant PatientsAmerican Journal of Transplantation, 2005
- Transplantation in the diabetic patient with advanced chronic kidney disease: A task force reportAmerican Journal of Kidney Diseases, 2004
- Transplantation in the diabetic patient with advanced chronic kidney disease: A task force reportAmerican Journal of Kidney Diseases, 2004
- Electrocardiographic Left Ventricular Hypertrophy in Renal Transplant RecipientsJournal of the American Society of Nephrology, 2003